Drugs / ZZSW-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07240974 | Oct 2025 → Sep 2028 expected | B-cell neoplasm | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ZZSW-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07240974 ↗ |
| Modality | Messenger RNA (mRNA) | “carries functional CD19 CAR mRNA” NCT07240974 ↗ |
| Route | Intravenous | “administered intravenously” NCT07240974 ↗ |